This cancer patient’s treatment is on hold because of the government shutdown
In April 2012, Michelle Langbehn was diagnosed with sarcoma, a rare form of cancer that affects 1 percent of cancer patients in the United States. After nine months of chemotherapy, she and her doctor began looking into other potential treatment options, including a trial at the National Institutes of Health.
Langbehn began filling out the paperwork to apply last month. Things were going well until late September, when she got a call from the NIH: If the government shut down, the trial would not accept new patients. Now, she is among an estimated 200 patients turned away each week from clinical trials there. Langbehn has started apetition asking the government to re-open the treatment option.
No comments:
Post a Comment